CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population
The aim of the study was to establish the frequencies of CYP2C9*1, *2, *3 and CYP2C19*1, *2 and *3 in the south Indian population and to compare them with the inter‐racial distribution of the CYP2C9 and CYP2C19 genetic polymorphisms. Genotyping analyses of CYP2C9 and CYP2C19 were conducted in unrela...
Gespeichert in:
Veröffentlicht in: | Fundamental & clinical pharmacology 2005-02, Vol.19 (1), p.101-105 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 105 |
---|---|
container_issue | 1 |
container_start_page | 101 |
container_title | Fundamental & clinical pharmacology |
container_volume | 19 |
creator | Jose, Rosemary Chandrasekaran, Adithan Sam, Soya Sisy Gerard, Nathalie Chanolean, Shashindran Abraham, Benny K. Satyanarayanamoorthy, K. Peter, Anitha Rajagopal, Krishnamoorthy |
description | The aim of the study was to establish the frequencies of CYP2C9*1, *2, *3 and CYP2C19*1, *2 and *3 in the south Indian population and to compare them with the inter‐racial distribution of the CYP2C9 and CYP2C19 genetic polymorphisms. Genotyping analyses of CYP2C9 and CYP2C19 were conducted in unrelated, healthy volunteers from the three south Indian states of Andhra Pradesh, Karnataka and Kerala, by the polymerase chain reaction–restriction fragment‐length polymorphism (PCR–RFLP). The allele frequencies of the populations of these three states were then pooled with our previous genotyping data of Tamilians (also in south India), to arrive at the distribution of CYP2C9 and CYP2C19 alleles in the south Indian population. Frequencies of CYP2C9 and CYP2C19 alleles and genotypes among various populations were compared using the two‐tailed Fisher's exact test. The frequencies of CYP2C9*1, *2 and *3 in the south Indian population were 0.88 (95% CI 0.85–0.91), 0.04 (95% CI 0.02–0.06) and 0.08 (95% CI 0.06–0.11), respectively. The frequencies of CYP2C9 genotypes *1/*1, *1/*2, *1/*3, *2/*2, *2/*3 and *3/*3 were 0.78 (95% CI 0.74–0.82), 0.05 (95% CI 0.03–0.07), 0.15 (95% CI 0.12–0.18), 0.01 (95% CI 0.0–0.02), 0.01 (95% CI 0.0–0.02) and 0.0, respectively. CYP2C19*1, *2 and *3 frequencies were 0.64 (95% CI 0.60–0.68), 0.35 (95% CI 0.31–0.39) and 0.01 (95% CI 0.0–0.03), respectively. As a result of a significant heterogeneity, the data on CYP2C19 genotype frequencies were not pooled. The frequency of CYP2C9*2 mutant alleles in south Indians was higher than in Chinese and Caucasians, while CYP2C9*3 was similar to Caucasians. CYP2C19*2 was higher than in other major populations reported so far. The relatively high CYP2C19 poor‐metabolizer genotype frequency of 12.6% indicates that over 28 million south Indians are poor metabolizers of CYP2C19 substrates. |
doi_str_mv | 10.1111/j.1472-8206.2004.00307.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67368932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67368932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5007-c96803eb7a6be0174ca6afd6eb7c26af48a30cea28424cd0b74ff41c8176b8ea3</originalsourceid><addsrcrecordid>eNqNkF1P2zAUhi00BAX2FybfbHcJx4lrO9NupogCAkElOk27shzHWd3lCzsR7b_HoRXczjc-sp_3-PhBCBOISViXm5hQnkQiARYnADQGSIHH2yM0e7_4hGbAGY_STJBTdOb9BoBwIOwEnZI5Y5AxNkOr_M8yyTOs2hK_lSTDf01rBqtx39W7pnP92vrGf8eVM8-jabU1HtsWD2uDfTcOa3zblla1Ae_HWg22ay_QcaVqbz4f9nP0a3G1ym-i-8fr2_znfaTnADzSGROQmoIrVpgwG9WKqapk4UQnoaJCpaCNSgRNqC6h4LSqKNGCcFYIo9Jz9G3ft3ddGM0PsrFem7pWrelGLxlPmcjSJIBiD2rXee9MJXtnG-V2koCcjMqNnMTJSZycjMo3o3Ibol8Ob4xFY8qP4EFhAL4eAOW1qiungiL_wTFKOSXzwP3Ycy-2Nrv_HkAu8mUoQjzax60fzPY9rty_6Zt8Ln8_XMvlgrFVLu7kU_oKnq6fvw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67368932</pqid></control><display><type>article</type><title>CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Jose, Rosemary ; Chandrasekaran, Adithan ; Sam, Soya Sisy ; Gerard, Nathalie ; Chanolean, Shashindran ; Abraham, Benny K. ; Satyanarayanamoorthy, K. ; Peter, Anitha ; Rajagopal, Krishnamoorthy</creator><creatorcontrib>Jose, Rosemary ; Chandrasekaran, Adithan ; Sam, Soya Sisy ; Gerard, Nathalie ; Chanolean, Shashindran ; Abraham, Benny K. ; Satyanarayanamoorthy, K. ; Peter, Anitha ; Rajagopal, Krishnamoorthy</creatorcontrib><description>The aim of the study was to establish the frequencies of CYP2C9*1, *2, *3 and CYP2C19*1, *2 and *3 in the south Indian population and to compare them with the inter‐racial distribution of the CYP2C9 and CYP2C19 genetic polymorphisms. Genotyping analyses of CYP2C9 and CYP2C19 were conducted in unrelated, healthy volunteers from the three south Indian states of Andhra Pradesh, Karnataka and Kerala, by the polymerase chain reaction–restriction fragment‐length polymorphism (PCR–RFLP). The allele frequencies of the populations of these three states were then pooled with our previous genotyping data of Tamilians (also in south India), to arrive at the distribution of CYP2C9 and CYP2C19 alleles in the south Indian population. Frequencies of CYP2C9 and CYP2C19 alleles and genotypes among various populations were compared using the two‐tailed Fisher's exact test. The frequencies of CYP2C9*1, *2 and *3 in the south Indian population were 0.88 (95% CI 0.85–0.91), 0.04 (95% CI 0.02–0.06) and 0.08 (95% CI 0.06–0.11), respectively. The frequencies of CYP2C9 genotypes *1/*1, *1/*2, *1/*3, *2/*2, *2/*3 and *3/*3 were 0.78 (95% CI 0.74–0.82), 0.05 (95% CI 0.03–0.07), 0.15 (95% CI 0.12–0.18), 0.01 (95% CI 0.0–0.02), 0.01 (95% CI 0.0–0.02) and 0.0, respectively. CYP2C19*1, *2 and *3 frequencies were 0.64 (95% CI 0.60–0.68), 0.35 (95% CI 0.31–0.39) and 0.01 (95% CI 0.0–0.03), respectively. As a result of a significant heterogeneity, the data on CYP2C19 genotype frequencies were not pooled. The frequency of CYP2C9*2 mutant alleles in south Indians was higher than in Chinese and Caucasians, while CYP2C9*3 was similar to Caucasians. CYP2C19*2 was higher than in other major populations reported so far. The relatively high CYP2C19 poor‐metabolizer genotype frequency of 12.6% indicates that over 28 million south Indians are poor metabolizers of CYP2C19 substrates.</description><identifier>ISSN: 0767-3981</identifier><identifier>EISSN: 1472-8206</identifier><identifier>DOI: 10.1111/j.1472-8206.2004.00307.x</identifier><identifier>PMID: 15660966</identifier><identifier>CODEN: FCPHEZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adult ; allele ; Aryl Hydrocarbon Hydroxylases - genetics ; Biological and medical sciences ; CYP2C19 ; CYP2C9 ; Cytochrome P-450 CYP2C19 ; Cytochrome P-450 CYP2C9 ; Female ; Gene Frequency ; Genetics, Population ; Humans ; India ; Male ; Medical sciences ; Mixed Function Oxygenases - genetics ; PCR-RFLP ; Pharmacology. Drug treatments ; Polymerase Chain Reaction ; polymorphism ; Polymorphism, Genetic ; Polymorphism, Restriction Fragment Length ; south India</subject><ispartof>Fundamental & clinical pharmacology, 2005-02, Vol.19 (1), p.101-105</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5007-c96803eb7a6be0174ca6afd6eb7c26af48a30cea28424cd0b74ff41c8176b8ea3</citedby><cites>FETCH-LOGICAL-c5007-c96803eb7a6be0174ca6afd6eb7c26af48a30cea28424cd0b74ff41c8176b8ea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1472-8206.2004.00307.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1472-8206.2004.00307.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27907,27908,45557,45558</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16447415$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15660966$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jose, Rosemary</creatorcontrib><creatorcontrib>Chandrasekaran, Adithan</creatorcontrib><creatorcontrib>Sam, Soya Sisy</creatorcontrib><creatorcontrib>Gerard, Nathalie</creatorcontrib><creatorcontrib>Chanolean, Shashindran</creatorcontrib><creatorcontrib>Abraham, Benny K.</creatorcontrib><creatorcontrib>Satyanarayanamoorthy, K.</creatorcontrib><creatorcontrib>Peter, Anitha</creatorcontrib><creatorcontrib>Rajagopal, Krishnamoorthy</creatorcontrib><title>CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population</title><title>Fundamental & clinical pharmacology</title><addtitle>Fundam Clin Pharmacol</addtitle><description>The aim of the study was to establish the frequencies of CYP2C9*1, *2, *3 and CYP2C19*1, *2 and *3 in the south Indian population and to compare them with the inter‐racial distribution of the CYP2C9 and CYP2C19 genetic polymorphisms. Genotyping analyses of CYP2C9 and CYP2C19 were conducted in unrelated, healthy volunteers from the three south Indian states of Andhra Pradesh, Karnataka and Kerala, by the polymerase chain reaction–restriction fragment‐length polymorphism (PCR–RFLP). The allele frequencies of the populations of these three states were then pooled with our previous genotyping data of Tamilians (also in south India), to arrive at the distribution of CYP2C9 and CYP2C19 alleles in the south Indian population. Frequencies of CYP2C9 and CYP2C19 alleles and genotypes among various populations were compared using the two‐tailed Fisher's exact test. The frequencies of CYP2C9*1, *2 and *3 in the south Indian population were 0.88 (95% CI 0.85–0.91), 0.04 (95% CI 0.02–0.06) and 0.08 (95% CI 0.06–0.11), respectively. The frequencies of CYP2C9 genotypes *1/*1, *1/*2, *1/*3, *2/*2, *2/*3 and *3/*3 were 0.78 (95% CI 0.74–0.82), 0.05 (95% CI 0.03–0.07), 0.15 (95% CI 0.12–0.18), 0.01 (95% CI 0.0–0.02), 0.01 (95% CI 0.0–0.02) and 0.0, respectively. CYP2C19*1, *2 and *3 frequencies were 0.64 (95% CI 0.60–0.68), 0.35 (95% CI 0.31–0.39) and 0.01 (95% CI 0.0–0.03), respectively. As a result of a significant heterogeneity, the data on CYP2C19 genotype frequencies were not pooled. The frequency of CYP2C9*2 mutant alleles in south Indians was higher than in Chinese and Caucasians, while CYP2C9*3 was similar to Caucasians. CYP2C19*2 was higher than in other major populations reported so far. The relatively high CYP2C19 poor‐metabolizer genotype frequency of 12.6% indicates that over 28 million south Indians are poor metabolizers of CYP2C19 substrates.</description><subject>Adult</subject><subject>allele</subject><subject>Aryl Hydrocarbon Hydroxylases - genetics</subject><subject>Biological and medical sciences</subject><subject>CYP2C19</subject><subject>CYP2C9</subject><subject>Cytochrome P-450 CYP2C19</subject><subject>Cytochrome P-450 CYP2C9</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genetics, Population</subject><subject>Humans</subject><subject>India</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mixed Function Oxygenases - genetics</subject><subject>PCR-RFLP</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymerase Chain Reaction</subject><subject>polymorphism</subject><subject>Polymorphism, Genetic</subject><subject>Polymorphism, Restriction Fragment Length</subject><subject>south India</subject><issn>0767-3981</issn><issn>1472-8206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkF1P2zAUhi00BAX2FybfbHcJx4lrO9NupogCAkElOk27shzHWd3lCzsR7b_HoRXczjc-sp_3-PhBCBOISViXm5hQnkQiARYnADQGSIHH2yM0e7_4hGbAGY_STJBTdOb9BoBwIOwEnZI5Y5AxNkOr_M8yyTOs2hK_lSTDf01rBqtx39W7pnP92vrGf8eVM8-jabU1HtsWD2uDfTcOa3zblla1Ae_HWg22ay_QcaVqbz4f9nP0a3G1ym-i-8fr2_znfaTnADzSGROQmoIrVpgwG9WKqapk4UQnoaJCpaCNSgRNqC6h4LSqKNGCcFYIo9Jz9G3ft3ddGM0PsrFem7pWrelGLxlPmcjSJIBiD2rXee9MJXtnG-V2koCcjMqNnMTJSZycjMo3o3Ibol8Ob4xFY8qP4EFhAL4eAOW1qiungiL_wTFKOSXzwP3Ycy-2Nrv_HkAu8mUoQjzax60fzPY9rty_6Zt8Ln8_XMvlgrFVLu7kU_oKnq6fvw</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Jose, Rosemary</creator><creator>Chandrasekaran, Adithan</creator><creator>Sam, Soya Sisy</creator><creator>Gerard, Nathalie</creator><creator>Chanolean, Shashindran</creator><creator>Abraham, Benny K.</creator><creator>Satyanarayanamoorthy, K.</creator><creator>Peter, Anitha</creator><creator>Rajagopal, Krishnamoorthy</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population</title><author>Jose, Rosemary ; Chandrasekaran, Adithan ; Sam, Soya Sisy ; Gerard, Nathalie ; Chanolean, Shashindran ; Abraham, Benny K. ; Satyanarayanamoorthy, K. ; Peter, Anitha ; Rajagopal, Krishnamoorthy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5007-c96803eb7a6be0174ca6afd6eb7c26af48a30cea28424cd0b74ff41c8176b8ea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>allele</topic><topic>Aryl Hydrocarbon Hydroxylases - genetics</topic><topic>Biological and medical sciences</topic><topic>CYP2C19</topic><topic>CYP2C9</topic><topic>Cytochrome P-450 CYP2C19</topic><topic>Cytochrome P-450 CYP2C9</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genetics, Population</topic><topic>Humans</topic><topic>India</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mixed Function Oxygenases - genetics</topic><topic>PCR-RFLP</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymerase Chain Reaction</topic><topic>polymorphism</topic><topic>Polymorphism, Genetic</topic><topic>Polymorphism, Restriction Fragment Length</topic><topic>south India</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jose, Rosemary</creatorcontrib><creatorcontrib>Chandrasekaran, Adithan</creatorcontrib><creatorcontrib>Sam, Soya Sisy</creatorcontrib><creatorcontrib>Gerard, Nathalie</creatorcontrib><creatorcontrib>Chanolean, Shashindran</creatorcontrib><creatorcontrib>Abraham, Benny K.</creatorcontrib><creatorcontrib>Satyanarayanamoorthy, K.</creatorcontrib><creatorcontrib>Peter, Anitha</creatorcontrib><creatorcontrib>Rajagopal, Krishnamoorthy</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fundamental & clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jose, Rosemary</au><au>Chandrasekaran, Adithan</au><au>Sam, Soya Sisy</au><au>Gerard, Nathalie</au><au>Chanolean, Shashindran</au><au>Abraham, Benny K.</au><au>Satyanarayanamoorthy, K.</au><au>Peter, Anitha</au><au>Rajagopal, Krishnamoorthy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population</atitle><jtitle>Fundamental & clinical pharmacology</jtitle><addtitle>Fundam Clin Pharmacol</addtitle><date>2005-02</date><risdate>2005</risdate><volume>19</volume><issue>1</issue><spage>101</spage><epage>105</epage><pages>101-105</pages><issn>0767-3981</issn><eissn>1472-8206</eissn><coden>FCPHEZ</coden><abstract>The aim of the study was to establish the frequencies of CYP2C9*1, *2, *3 and CYP2C19*1, *2 and *3 in the south Indian population and to compare them with the inter‐racial distribution of the CYP2C9 and CYP2C19 genetic polymorphisms. Genotyping analyses of CYP2C9 and CYP2C19 were conducted in unrelated, healthy volunteers from the three south Indian states of Andhra Pradesh, Karnataka and Kerala, by the polymerase chain reaction–restriction fragment‐length polymorphism (PCR–RFLP). The allele frequencies of the populations of these three states were then pooled with our previous genotyping data of Tamilians (also in south India), to arrive at the distribution of CYP2C9 and CYP2C19 alleles in the south Indian population. Frequencies of CYP2C9 and CYP2C19 alleles and genotypes among various populations were compared using the two‐tailed Fisher's exact test. The frequencies of CYP2C9*1, *2 and *3 in the south Indian population were 0.88 (95% CI 0.85–0.91), 0.04 (95% CI 0.02–0.06) and 0.08 (95% CI 0.06–0.11), respectively. The frequencies of CYP2C9 genotypes *1/*1, *1/*2, *1/*3, *2/*2, *2/*3 and *3/*3 were 0.78 (95% CI 0.74–0.82), 0.05 (95% CI 0.03–0.07), 0.15 (95% CI 0.12–0.18), 0.01 (95% CI 0.0–0.02), 0.01 (95% CI 0.0–0.02) and 0.0, respectively. CYP2C19*1, *2 and *3 frequencies were 0.64 (95% CI 0.60–0.68), 0.35 (95% CI 0.31–0.39) and 0.01 (95% CI 0.0–0.03), respectively. As a result of a significant heterogeneity, the data on CYP2C19 genotype frequencies were not pooled. The frequency of CYP2C9*2 mutant alleles in south Indians was higher than in Chinese and Caucasians, while CYP2C9*3 was similar to Caucasians. CYP2C19*2 was higher than in other major populations reported so far. The relatively high CYP2C19 poor‐metabolizer genotype frequency of 12.6% indicates that over 28 million south Indians are poor metabolizers of CYP2C19 substrates.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>15660966</pmid><doi>10.1111/j.1472-8206.2004.00307.x</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0767-3981 |
ispartof | Fundamental & clinical pharmacology, 2005-02, Vol.19 (1), p.101-105 |
issn | 0767-3981 1472-8206 |
language | eng |
recordid | cdi_proquest_miscellaneous_67368932 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adult allele Aryl Hydrocarbon Hydroxylases - genetics Biological and medical sciences CYP2C19 CYP2C9 Cytochrome P-450 CYP2C19 Cytochrome P-450 CYP2C9 Female Gene Frequency Genetics, Population Humans India Male Medical sciences Mixed Function Oxygenases - genetics PCR-RFLP Pharmacology. Drug treatments Polymerase Chain Reaction polymorphism Polymorphism, Genetic Polymorphism, Restriction Fragment Length south India |
title | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T16%3A08%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CYP2C9%20and%20CYP2C19%20genetic%20polymorphisms:%20frequencies%20in%20the%20south%20Indian%20population&rft.jtitle=Fundamental%20&%20clinical%20pharmacology&rft.au=Jose,%20Rosemary&rft.date=2005-02&rft.volume=19&rft.issue=1&rft.spage=101&rft.epage=105&rft.pages=101-105&rft.issn=0767-3981&rft.eissn=1472-8206&rft.coden=FCPHEZ&rft_id=info:doi/10.1111/j.1472-8206.2004.00307.x&rft_dat=%3Cproquest_cross%3E67368932%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67368932&rft_id=info:pmid/15660966&rfr_iscdi=true |